ESR1 and breast cancer: Interestingly, we found that the mutation frequency in HR coding regions (15%) is lower than that for BRCA2 (23%), but higher than those of other BC susceptibility genes including BRCA1 (7%), ESR1 (3%), and PTEN (3%) (Figure 1A).